Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine dose-finding study in pediatric dilated cardiomyopathy with chronic heart failure
ISRCTN60567801Phase 3Completed
- Sponsor
- Servier
- Start
- Oct 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in dilated cardiomyopathy (DCM) and chronic heart failure (CHF) comparing Ivabradine with Placebo (2 arms). Primary endpoints: Pharmacokinetics and PK/PD characterization and Target heart rate achievement. Started Oct 2011; status: completed.
02
Drugs
ivabradine
03
Conditions
dilated cardiomyopathy (DCM)chronic heart failure (CHF)
Beyond the preview
Go deeper on ISRCTN60567801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60567801.